Literature DB >> 15347281

Japanese encephalitis acquired near Port Moresby: implications for residents and travellers to Papua New Guinea.

Joshua P Hanson, Carmel T Taylor, Ann R Richards, Ina L Smith, Craig S Boutlis.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15347281     DOI: 10.5694/j.1326-5377.2004.tb06274.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

1.  Contribution of dengue fever to the burden of acute febrile illnesses in Papua New Guinea: an age-specific prospective study.

Authors:  Nicolas Senn; Dagwin Luang-Suarkia; Doris Manong; Peter Max Siba; William John Hannan McBride
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  Japanese encephalitis in travelers from non-endemic countries, 1973-2008.

Authors:  Susan L Hills; Anne C Griggs; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

3.  Japanese B Encephalitis: An Overview of the Disease and Use of Chimerivax-JE as a Preventative Vaccine.

Authors:  Ruth Chin; Joseph Torresi
Journal:  Infect Dis Ther       Date:  2013-11-19

Review 4.  Epidemiology of Japanese encephalitis: past, present, and future prospects.

Authors:  Huanyu Wang; Guodong Liang
Journal:  Ther Clin Risk Manag       Date:  2015-03-19       Impact factor: 2.423

Review 5.  Early Events in Japanese Encephalitis Virus Infection: Viral Entry.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  Pathogens       Date:  2018-08-13

6.  Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Susan L Hills; Emmanuel B Walter; Robert L Atmar; Marc Fischer
Journal:  MMWR Recomm Rep       Date:  2019-07-19

7.  The epidemiology and outcomes of central nervous system infections in Far North Queensland, tropical Australia; 2000-2019.

Authors:  Hannah Gora; Simon Smith; Ian Wilson; Annie Preston-Thomas; Nicole Ramsamy; Josh Hanson
Journal:  PLoS One       Date:  2022-03-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.